Literature DB >> 6502516

Loperamide: blockade of calcium channels as a mechanism for antidiarrheal effects.

I J Reynolds, R J Gould, S H Snyder.   

Abstract

The antidiarrheal opiates loperamide, fluperamide, diphenoxylate and fetoxylate inhibited binding of [3H]nitrendipine to membranes from guinea-pig cerebral cortex with Ki values of 0.5 to 10 microM. Loperamide and fluperamide reversed the tiapamil elicited lowering of [3H]nitrendipine binding with IC50 values of 0.2 to 0.5 microM, indicating a verapamil-like action of these drugs. An oral dose of 1 mg/kg of loperamide reduced gastrointestinal motility and gave concentrations of 0.45 +/- 0.19, 0.38 +/- 0.22 and 0.49 +/- 0.25 microM in the duodenum, jejunum and ileum, respectively. The apparent Ki for loperamide in preventing calcium-induced contractions of guinea-pig ileum depolarized with 80 mM potassium was 0.10 microM. We propose that calcium channel antagonism is responsible at least in part for the antidiarrheal actions of loperamide and related agents. Evidence includes the calcium antagonist actions of loperamide at antidiarrheal doses, the constipating effects of certain calcium antagonists and the failure of opiate antagonists to prevent some intestinal effects of loperamide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6502516

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

1.  Effects of the prodrug loperamide oxide, loperamide, and placebo on jejunal motor activity.

Authors:  G Stacher; H Steinringer; C Schneider; G V Vacariu-Granser; F Castiglione; G Gaupmann; U Weber; G Stacher-Janotta
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

2.  Loperamide dependence and abuse.

Authors:  Ryan MacDonald; Jason Heiner; Joshua Villarreal; Jared Strote
Journal:  BMJ Case Rep       Date:  2015-05-02

3.  Secretagogue-induced changes in membrane calcium permeability in chicken and chinchilla ileal mucosa. Selective inhibition by loperamide.

Authors:  E B Chang; D R Brown; N S Wang; M Field
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  Stimulation of gastrointestinal motility by loperamide in dogs.

Authors:  J Fioramonti; M J Fargeas; L Bueno
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

Review 5.  Loperamide cardiotoxicity: "A Brief Review".

Authors:  Tamer Akel; Soad Bekheit
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-11-10       Impact factor: 1.468

6.  Pharmacological explanation for the medicinal use of Juniperus excelsa in hyperactive gastrointestinal and respiratory disorders.

Authors:  Munasib Khan; Arif-ullah Khan; Anwarul-Hassan Gilani
Journal:  J Nat Med       Date:  2011-12-03       Impact factor: 2.343

7.  Loperamide abolishes exercise-induced orocecal liquid transit acceleration.

Authors:  W F Keeling; A Harris; B J Martin
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

8.  Loperamide improves anal sphincter function and continence after restorative proctocolectomy.

Authors:  T Hallgren; S Fasth; D S Delbro; S Nordgren; T Oresland; L Hultén
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

9.  Loperamide mobilizes intracellular Ca2+ stores in insulin-secreting HIT-T15 cells.

Authors:  Li-Ping He; David Mears; Illani Atwater; Eduardo Rojas; Lars Cleemann
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 10.  Antidiarrheal therapy. Prospects for new agents.

Authors:  R N Fedorak; M Field
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.